We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




First International Guidelines on Lung Disease

By HospiMedica staff writers
Posted on 01 Jun 2001
The first international guidelines for the diagnosis, management, and prevention of chronic obstructive lung disease (COPD) have been released by an international team of scientists from the Global Initiative for Chronic Obstructive Lung Disease (GOLD). More...
GOLD was created by the U.S. National Heart, Lung, and Blood Institute (NHLBI) at the U.S. National Institutes of Health and the World Health Organization.

Called the GOLD Workshop Report, the guidelines provides evidence-based recommendations for the clinical management of COPD and are the first step in an international effort to boost awareness of COPD and improve the way it is treated. The report emphasizes the need for clinicians and patients to recognize cough and sputum production as early signs of possible COPD and calls for the use of spirometry to confirm diagnosis. It also provides a general scheme for classifying COPD by severity to help clinicians determine how best to manage the condition. Practical recommendations for reducing risk factors and for managing both stable COPD and exacerbations are also provided.

COPD has been on the increase, with the number of U.S. deaths alone increasing to around 100,000 men and women per year. The highest rate of U.S. increase has been in white women. According to the National Institutes of Health, COPD will rank as the third leading cause of death, surpassing stroke, by 2020.
"A concerted effort by government officials, health care workers, biomedical researchers, industry, and patients throughout the world is required to improve the way COPD is diagnosed and managed and to increase research into improved treatments and ultimately a cure,” said Dr. Claude Lenfant, director of the NHLBI. "This effort has begun with the launch of the GOLD Initiative today.”

Copies of the GOLD Workshop Report and other information on COPD are available on the NHLBI website (www.nhlbi.nih.gov).




Related Links:
NHLBI

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.